首页> 外文期刊>Journal of Medicinal Chemistry >Novel Benzoaquinolizidine Analogs Induce Cancer Cell Death through Paraptosis and Apoptosis
【24h】

Novel Benzoaquinolizidine Analogs Induce Cancer Cell Death through Paraptosis and Apoptosis

机译:新型苯并a喹啉西啶类似物通过上睑下垂和细胞凋亡诱导癌细胞死亡

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Paraptosis is nonapoptotic cell death characterized by massive endoplasmic reticulum (ER)- or mitochondria-derived vacuoles. Induction of paraptosis offers significant advantages for the treatment of chemotherapy-resistant tumors compared with anticancer drugs that rely on apoptosis. Because some natural alkaloids induce paraptotic cell death, a novel series of benzoaquinolizidine derivatives were synthesized, and their antiproliferative activity and ability to induce cytoplasmic vacuolation were analyzed. Structural optimization led to the identification of the potent compound 22b, which inhibited cancer cell proliferation in vitro and in vivo and profoundly facilitated paraptosis-like cell death and induced caspase-dependent apoptosis. Further investigation revealed that 22b-mediated vacuolation originated from persistent ER stress and upregulation of LC3B. Paraptosis induced by benzoaquinolizidine derivatives thus represents an alternative strategy for cancer chemotherapy.
机译:副上睑下垂是非凋亡性细胞死亡,其特征是大量内质网 (ER) 或线粒体衍生的液泡。与依赖细胞凋亡的抗癌药物相比,上睑下垂诱导在治疗化疗耐药性肿瘤方面具有显着优势。由于一些天然生物碱诱导下垂旁细胞死亡,因此合成了一系列新型苯并[a]喹啉西啶衍生物,并分析了其抗增殖活性和诱导细胞质空泡化的能力。结构优化导致了有效化合物22b的鉴定,该化合物在体外和体内抑制癌细胞增殖,并极大地促进了旁睑下垂样细胞死亡并诱导了半胱天冬酶依赖性细胞凋亡。进一步的研究表明,22b介导的空泡化源于持续的ER应激和LC3B的上调。因此,苯并[a]喹啉西啶衍生物诱导的上睑下垂代表了癌症化疗的替代策略。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号